CLINICAL TRIAL PROFILE · UPDATED 2026-09-29

A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 18-59 Year Olds

NCT06226714 · Phase 3 · Active Not Recruiting

PHASEPhase 3

STATUSActive Not Recruiting

ENROLLMENT840

EST. COMPLETION2024-09-26

Conditions

Meningococcal Meningitis

Interventions

MCV4MPSV4

Study details

SPONSORCanSino Biologics Inc.

START DATE2024-03-01

Related company profiles

CanSino Biologics

6185.HK

Primary source

ClinicalTrials.gov record NCT06226714 ↗

Trial status and dates can change. Confirm enrollment and eligibility against the linked ClinicalTrials.gov record.

Evidence & limits

Source: Open the source record

Record identifier: NCT06226714
Event / action date: Not separately retained
Source update date: Not separately retained
Platform retrieval / processing date: Not separately retained

What it supports. Study information reported by the sponsor or investigator, including status, phase, enrollment, and recorded dates.

Limits. Registration or completion does not establish clinical success or approval. Sponsor-name associations can be ambiguous. Dates may be estimated; verify the live study record.

Connection basis. Company sponsor aliases and normalized lead-sponsor containment; the NCT identifier identifies the study.

What this record means · Report an issue with this record